Thromboembolism prevention is a fundamental pillar of cardiovascular care, requiring careful balancing of clot risk against bleeding risk. The Anticoagulation Management session focuses on how clinicians can select and adjust therapies for patients with atrial fibrillation, venous thromboembolism, mechanical heart valves, acute coronary syndromes, and complex comorbidities. Participants will explore dosing strategies, drug–drug interactions, renal and hepatic considerations, and practical tools for monitoring and reversal. This session is designed for cardiologists, internists, hospitalists, pharmacists, and nurses who want to build confident, guideline-aligned approaches to anticoagulant therapy across inpatient and outpatient settings.

As practice evolves, many practitioners look for an cardiology conference to align with current evidence on vitamin K antagonists, direct oral anticoagulants (DOACs), low-molecular-weight heparins, and parenteral agents. The session reviews how to choose between warfarin and DOACs, tailor therapy to stroke and embolic risk, and interpret risk scores such as CHA?DS?-VASc and HAS-BLED. Attendees will learn how to manage peri-procedural anticoagulation, bridging decisions, and transitions between agents when renal function fluctuates or drug interactions arise. Real-world cases will examine scenarios such as elderly patients with falls, patients with cancer-associated thrombosis, and those with both coronary stents and atrial fibrillation requiring careful regimen integration.

A major emphasis is placed on thrombosis prevention strategies that combine pharmacologic and non-pharmacologic measures. Participants will explore how to coordinate mechanical prophylaxis, lifestyle counseling, and shared decision-making to personalize anticoagulation intensity and duration. The session also addresses anticoagulation in pregnancy, extremes of body weight, and special populations such as those with left ventricular assist devices or structural heart interventions. Guidance on managing bleeding events, using reversal agents, and building institutional protocols for rapid response will help teams implement safe, efficient systems.

Quality improvement and patient education are woven throughout the discussion. Attendees will see how anticoagulation clinics, digital monitoring platforms, and structured patient counseling can improve adherence and reduce avoidable complications. By the end of the session, participants will have a practical framework for prescribing, adjusting, and reviewing anticoagulation therapy in a way that optimizes protection from thromboembolic events while minimizing bleeding risk.